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Background: San-Huang-Xie-Xin-Tang (SHXXT) decoction, a traditional Chinese   medicine 
containing Rhei rhizome, Coptidis rhizome, and Scutellariae radix, is widely used in 
  hepatoprotective therapy. However, preparation of the decoction requires addition of boiling 
water that causes loss of numerous effective components.
Methods: To improve the bioavailability of the decoction, nanoscale SHXXT was   developed. 
Chloroform-induced liver injury and hepatic stellate cell activity in mice were used to 
  demonstrate the hepatoprotective characteristics of nanoscale SHXXT decoction.
Results: Liver/body weight ratio and serum aspartate and alanine aminotranferase levels were 
recovered by the nanoscale SHXXT. TIMP-1 gene expression was inhibited and MMP-2 gene 
expression was accelerated in activated hepatic stellate cells.
Conclusion: Nanoscale SHXXT decoction prepared in room temperature water could have 
preserved hepatoprotective ability. The results of this study indicate that nanoscale SHXXT 
could be extracted easily. The simple preparation of this herbal decoction is more convenient 
and energy-efficient.
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Introduction
There has been a tremendous wave of interest in the mechanism of liver fibrosis 
in the last few decades. A growing number of research studies are shedding light on 
the relationship between liver fibrosis and herbal medicine therapy. Liver fibrosis is 
a dynamic and reversible wound healing process of chronic liver injury that tends to 
result in cirrhosis and hepatoma. Liver fibrosis is usually caused by viral hepatitis 
infection, alcohol abuse, or nonalcoholic steatohepatitis. The fibrotic process involves 
excessive deposition of extracellular matrix in liver tissue.1,2 San-Huang-Xie-Xin-Tang 
(SHXXT) decoction is a traditional hepatoprotective Chinese herbal medicine, com-
prising Rhei rhizome (rhizomes of Rheum officinale Baill.), Scutellariae radix (roots 
of Scutellaria baicalensis Georgi.), and Coptidis rhizoma (rhizomes of Coptis chinesis 
Franch.) at a ratio of 2:1:1.3 SHXXT decoction is widely used in anti-inflammatory4,5 
and antioxidant3 preparations. SHXXT decoction can also regulate the expression of 
genes involved in p53 signaling, p53 activation, and DNA damage signaling path-
ways in hepatocytes. Furthermore, the regulation of SHXXT may be associated with 
antiproliferation patterns.6
As with most Chinese herbal medicines, SHXXT decoction is extracted in   boiling 
water to release the biological components. However, poor solubility decreases 
  bioavailability, so considerable quantities of these herbal drugs must be used.7–9 International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1366
Huang et al
Increasing the dissolution rate of hydrophobic drugs is 
the key to overcoming these obstacles. According to the 
Noyes–Whitney equation, decreased particle size gives rise 
to increased drug surface area and dissolution velocity.10–12 
Due to the larger surface area of nanoparticles per mass unit, 
researchers have proposed that these are more biologically 
active than bulky particles with the same constituent. Nano-
scale Chinese herbal drugs can typically be defined as drug 
systems with particles in the size range of 10–1000 nm.13
To evaluate the effect of nanoscale SHXXT decoction 
on injured livers, chloroform was used in this study to cause 
liver damage in mice. Chloroform can increase the liver/body 
weight ratio and the cell nuclear antigen-labeling index.14 
Cytochrome P450-dependent chloroform metabolism is lost 
during repeated chloroform treatments in B6C3F1 mice.15 
Chloroform-induced liver injury in rodents is an effective 
animal model for the assessment of drug therapy.16 One of 
the major sources of extracellular matrix proteins that con-
tribute to the process of liver fibrosis is the hepatic stellate 
cell. During liver fibrogenesis, an increase in hepatic stellate 
cell proliferation and upregulation of extracellular matrix 
proteins is typical. A transformation growth factor-beta 1 
(TGF-β1)-activated hepatic stellate cell culture model has 
been used in several studies.17–21
This study investigated the hepatoprotective ability of a 
nanoscale SHXXT decoction prepared with room temperature 
water. Microscale SHXXT decoction prepared with boiling 
water was used as the comparator group. Two models, in vivo 
and in vitro, were examined in this study. Female imprinting 
control region mice were exposed to chloroform twice a week 
to induce liver damage, after which the nanoscale SHXXT 
decoction prepared with room temperature water was applied 
to cure the mice. Liver/body weight ratio, serum aspartate 
aminotransferase (AST), alanine aminotranferase (ALT), and 
histological features of the liver were investigated. In the cell 
culture assay, TGF-β1 was applied to induce hepatic stellate 
cell activity, and then treated with nanoscale SHXXT decoc-
tion or microscale SHXXT decoction. TMTT activity, and 
MMP-2 and TIMP-1 mRNA expression were determined. 
The intention of this study was to contrast the two methods 
and to determine if the nanoscale SHXXT decoction prepared 
with room temperature water has hepatoprotective activity.
Material and methods
Preparation of nanoscale sHXXT
Chinese herbal SHXXT containing Rhei rhizome, Scutel-
lariae radix, and Coptidis rhizome was purchased from the 
China Medical University. Dried mixtures of Rhei rhizome/
Scutellariae radix/Coptidis rhizome (2:1:1 by weight) were 
nanoscaled with the aid of a pulsed air-flow pulverizer 
(Diamond Nano-Biochem Company, Taiwan). Briefly, the 
herbal mixture was ground into small pieces (3 mm). After-
wards, the small pieces were placed into the chamber of the 
pulsed air-flow pulverizer. The airflow provided the collision 
between the herbal mixtures. Thus, the particle size of the 
herbal mixture was attenuated to nanoscale. The powders 
were stored at room temperature until analysis.
Measurement of hydrodynamic diameters 
of nanoscale sHXXT
The hydrodynamic diameters of nanoscale SHXXT were 
examined by dynamic laser light scattering in the single 
scattering regime with λ = 532 nm (Zeta Sizer Nano ZS; 
Malvern Instruments Ltd, Worcestershire, UK). Typically, 
nanoscale SHXXT was suspended in Milli-Q water (1.5 mL) 
using ultrasonic vibration at a concentration of 0.1 mg/mL. 
The suspension was put into a cuvette at 25° ± 1°C to enable 
analysis of particle size. The viscosity and refractive index of 
the continuous phase were set to those specific for water.
Field emission scanning electron 
microscopy
To demonstrate the morphology of nanoscale SHXXT, the 
samples were examined by field emission scanning electron 
microscopy (S-4100; Hitachi, Tokyo, Japan) operating at 
15 kV. The samples used were prepared by suspending 
1 mg of nanoscale SHXXT in 1 mL of Milli-Q water. The 
suspended nanoparticles were pipetted in 200 µL amounts 
onto the holder, and dehydrated. To enhance electrical con-
ductivity, the samples were coated with platinum via sput-
tering (SPI-Module Sputter Coater; SPI Supplies – Structure 
Probe, Inc, West Chester, PA) before examination.
Preparation of nanoscale sHXXT 
decoction
Nanoscale SHXXT (200 g) was extracted with 1 L of room 
temperature Milli-Q water, whereas microscale SHXXT 
(200 g) was extracted with 1 L of boiling Milli-Q water. 
The aqueous extract, called nanoscale SHXXT decoction 
and microscale SHXXT decoction, was separated from the 
nanoscale SHXXT particles and microscale SHXXT particles 
by filters and then used for the experiment.
experimental animals
Laboratory-bred, 6–8 week-old imprinting control region 
mice sourced from the National Taiwan University Hospital, International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Taipei, Taiwan, were used in this study. The animals were 
housed at 21°–25°C, a relative humidity of 30%–70% and 
on a 12-hour/12-hour day/night cycle. Pelleted mouse feed 
(MF Laboratory Animal Diet, Oriental Yeast, Tokyo, Japan) 
and reverse-osmosis water were provided ad libitum. All pro-
cedures used in this study were approved by the institutional 
animal ethics committee.
Animal treatment
To investigate the protective effects of nanoscale SHXXT 
decoction against liver injury, the mice were divided into 
four groups: a control group, which was neither admin-
istered SHXXT decoction nor exposed to chloroform; 
a chloroform group, which was administered chloroform 
but was not exposed to SHXXT decoction; a microscale 
SHXXT decoction treatment group, which was adminis-
tered the microscale SHXXT decoction and chloroform; 
and a nanoscale SHXXT decoction treatment group, which 
was administered the nanoscale SHXXT decoction and 
chloroform. SHXXT was administered via the intragastric 
route at a dose of 2.9 mL/kg per day for 8 weeks. In the 
same way, chloroform was intragastrically administered 
at a dose of 0.2 mL/kg twice per week for 8 weeks. Each 
group included eight mice. At the end of the experiment, 
all the mice were sacrificed, and their livers and blood were 
collected immediately. Liver weights were subsequently 
measured.
AsT and ALT measurement
Blood was obtained from the vena cava before autopsy, and 
the serum was isolated and stored at -80°C until analysis. 
Serum AST and ALT levels were estimated using commercial 
kits (Human Diagnostics, Wiesbaden, Germany) according 
to the manufacturer’s protocols.
Histological analysis
Liver tissue was isolated, fixed in 10% buffered neutral 
formalin, and processed for paraffin embedding. Thereafter, 
the tissue was cut into 5 µm thin sections and stained with 
hematoxylin and eosin solution. Hepatic morphology was 
assessed by light microscopy.
cell culture
The hepatic stellate cells used in this study were gifted 
from Professor Friedman (Division of Liver Diseases, 
Mount Sinai School of Medicine, New York). The 
cells were grown to confluence in a T-75 flask (Falcon, 
Heidelberg, Germany) in a Waymouth MB 752/1 medium 
  supplemented with 10% fetal bovine serum at 37°C in 
a 5% CO2 atmosphere.
Detection of hepatic stellate cell 
proliferation
Hepatic stellate cell proliferation was measured using 
a colorimetric MTT [3-(4,5-dimethylthiazolyl-2)-2, 5-di-
phenyltetrazolium bromide] assay. After 7 days of culture, 
the hepatic stellate cells were transferred into flat-bottomed 
96-well microtiter plates at a seeding density of 2 × 103 
cells/well, and were cultured again for 24 hours. The cul-
ture medium was removed and replaced by Waymouth MB 
752/1 medium containing the microscale SHXXT decoction 
or the nanoscale SHXXT decoction. After 48 hours, the 
culture medium was removed again and replaced by Way-
mouth MB 752/1 medium containing MTT. The cells were 
then incubated for another 4 hours prior to the MTT assays, 
which were then performed using a Spectra Max 190 plate 
reader (Molecular Devices, Toronto, ON). The results were 
obtained at 570 nm. The optical density values of groups 
treated with microscale SHXXT decoction and nanoscale 
SHXXT decoction were compared with the TGF-β1 induced 
only group. Each experiment was performed eight times in 
each group.
reverse-transcription polymerase chain 
reaction analysis
The hepatic stellate cells were seeded in six-well plates at 
a seeding density of 200,000 cells/well and treated with 
2 ng/mL TGF-β1 and 500 µg/mL microscale SHXXT decoc-
tion or nanoscale SHXXT decoction for 24 hours. Total RNA 
was isolated using the Geneaid kit (Geneaid, Taipei, Taiwan) 
according to the manufacturer’s instructions. First-strand 
complementary DNA was synthesized from 5.0 µg total RNA 
per 30 µL reaction volume. The polymerase chain reaction was 
performed using the following primers: rat MMP-2 (604 bp), 
5′-GTGCTGAAGGACACCCTCAAGAAGA-3′ (sense) and 
5′-TTGCCGTCCTTCTCAAAGTTGTACG-3′ (antisense), 
rat TIMP-1 (310 bp), 5′-GCCATGGAGAGCCTCTGTGG-3′ 
(sense) and 5′-GCAGGCAGGCAAAGTGATCG-3′ 
(antisense), and rat GAPDH (74 bp), 5′-AACTACAT-
GGTCTACATGTTCCA-3′ (sense) and 5′-CCATTCT-
CGGCCTTGACTGT-3′ (antisense). All reactions were 
performed in a total volume of 30 µL containing 3 µL 
10 × polymerase chain reaction buffer, 0.5 µL 5 U Taq DNA 
polymerase, 1 µL 10 mM dNTP, 2 µL target primer mixture, 
and 1 µL cDNA as a template. The products of polymerase 
chain reaction were analyzed using 2% agarose gels and International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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ethidium bromide staining. The products were then visualized 
under ultraviolet light and saved digitally with a UVIdoc gel 
documentation system (Uvitec, Cambridge, UK).
statistical analysis
Data were expressed as mean ± standard error values and 
analyzed statistically using one-way analysis of variance 
followed by Scheffé’s test using SPSS (v 14.0; SPSS, Inc, 
Chicago, IL) to establish the significance of any differences. 
The level of statistical significance was set at P , 0.05.
Results and discussion
Particle size distribution of nanoscale 
sHXXT
The size and shape of the nanoscale SHXXT were deter-
mined by zeta sizer and field emission scanning electron 
microscopy. The measurements were performed by dispers-
ing the nanoscale SHXXT in Milli-Q water using ultrasonic 
vibration. From the dynamic laser light scattering data 
presented in Figure 1A, the mean diameters of nanoscale 
SHXXT were determined to be approximately 600 nm. The 
field emission scanning electron photomicrograph of the 
nanoscale SHXXT particles shown in Figure 1B illustrates 
the oblong shape and confirms the size of the particles to be 
similar to the zeta size results. These data indicate that the 
dried SHXXT was successfully nanoscaled by pulsed air-
flow pulverizer. The pulsed air-flow pulverizer was applied 
to the herbal nanoparticles22–24 and calcium nanoparticle25 
preparations.
changes in ratio of liver/body weight  
by nanoscale sHXXT decoction
The ratio of liver/body weight was increased by oral 
administration of chloroform (Figure 2A). Chloroform 
caused dose-dependent increases in liver/body weight 
ratios.14 Chloroform is toxic to the liver. Furthermore, 
mice receiving the microscale SHXXT decoction and the 
nanoscale SHXXT decoction had a lower liver/body weight 
ratio during the chloroform treatment period (Figure 2A). 
These results suggest that the nanoscale SHXXT decoc-
tion reduced the chloroform-induced liver/body weight 
ratio gain.
changes in serum ALT and AsT
ALT and AST are often used as markers for evaluating liver 
function.26,27 In the present study, ALT and AST   activity was 
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Figure 1 size and shape of the nanoscale sHXXT decoction. A) Zeta sizer picture of nanoscale sHXXT showing size distribution in Milli-Q water. B) Field emission scanning 
electron microscopy picture of nanoscale sHXXT on a solid substrate.
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significantly increased after chloroform exposure (P , 0.05) as 
compared with controls (Figures 2B and 2C).   Administration 
of the microscale SHXXT decoction and the nanoscale 
SHXXT decoction decreased the chloroform-induced increase 
in ALT and AST activity. Treatment with the microscale 
SHXXT decoction and the nanoscale SHXXT decoction 
(2.9 mL/kg body weight) reversed the liver damage caused 
by chloroform.
Histological examination
In the sections of control liver tissue, the hepatocytes are 
arranged in strands with one or two spherical nuclei, and 
the sinusoids were occupied by blood cells. The cytoplasm 
of the hepatic cells was slightly eosinophilic, and the 
central vein generally had a circular outline (Figure 3A). 
Chloroform produced hepatic necrosis, inflammation, 
fatty accumulation, and fibrosis after 8 weeks (Figure 3B). 
Necrosis, inflammation, fatty accumulation, and fibrosis 
were significantly lower in the groups treated with the 
microscale SHXXT decoction and the nanoscale SHXXT 
decoction when compared with the chloroform-treated 
groups (Figures 3C and 3D). Histopathological evaluation 
was performed twice for four sections per slide from all 
animals in each group.
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Figure  3  Liver  tissue  sections  of  A)  control  group,  B)  chloroform  group, 
C) microscale sHXXT decoction group, and D) nanoscale sHXXT decoction group 
stained with hematoxylin and eosin.
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MTT assay
The results of the MTT assay demonstrated that hepatic 
stellate cells exposed to the nanoscale SHXXT decoction 
for 48 hours resulted in dose-dependent inhibition. At 
0.8 mg/mL and 1 mg/mL concentrations of the microscale 
SHXXT decoction and nanoscale SHXXT decoction, the 
viability of hepatic stellate cells was reduced significantly 
(Figure 4A). Viability in the nanoscale SHXXT decoction 
groups was more efficient than in the microscale SHXXT 
decoction groups.
reverse transcription polymerase chain 
reaction
Results from the polymerase chain reaction analysis show 
the changes in mRNA levels of fibrogenesis-related genes 
(Figure 4B). TGF-β1 is an activation factor in hepatic   stellate 
cells. The expression of TIPM-1, a fibrogenesis-related 
gene, was upregulated by TGF-β1. Expression of MMP-2, 
an antifibrogenesis-related gene, was downregulated by 
TGF-β1. However, the nanoscale SHXXT decoction and 
the nanoscale SHXXT decoction attenuated the activity of 
TGF-β1 in hepatic stellate cells. The nanoscale SHXXT 
decoction exhibited more efficiency than the nanoscale 
SHXXT decoction.
Conclusion
According to this study, the pulsed air-flow pulverizer can 
produce nanoscale Chinese herbal medicine efficiently. 
This method could help us to improve the bioavailability of 
traditional Chinese herbal medicine. The herbal   decoction 
can be prepared using room temperature water rather than 
boiling water. The pharmaceutical activity of the nanoscale 
SHXXT decoction was retained. The results of this study 
indicate that nanoscale SHXXT particles can be extracted 
easily. Simple preparation of a herbal decoction using this 
method is more convenient and energy-efficient.
Downregulation of the liver/body weight ratio and a decrease 
in AST and ALT levels in chloroform-induced liver injury dem-
onstrated the excellent recovery ability of the nanoscale SHXXT 
decoction. The inhibition of TIMP-1 gene expression and 
acceleration of MMP-2 gene expression in the activated hepatic 
stellate cells suggests that the nanoscale SHXXT decoction may 
block the development and progression of liver fibrosis by alter-
ing matrix degradation. However, further studies are required 
to clarify the pathophysiologic role of this nanoscale SHXXT 
decoction in the process of liver fibrosis and cirrhosis.
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